AN2 Therapeutics (ANTX)

• Market cap: $30.1M
• 1 day: 2.8%
• 5 days: 4.76%
• 1 month: -3.51%
• 3 months: -12.7%
• 6 months: -0.9%
• Year to date: -20.86%
• 1 year: -24.14%
• 5 years: -92.86%
• 10 years: -92.86%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36